Sudhir Borgonha
Chief Executive Officer bei Translational Medicine India, Inc.
Profil
Sudhir Borgonha was the founder of Ten3T Healthcare Pvt Ltd.
(founded in 2014) where he served as the Chief Executive Officer & Director from 2014 to 2020.
Dr. Borgonha is also the founder of Angstrom Medica, Inc. Dr. Borgonha's current jobs include being the Chief Executive Officer at Translational Medicine India, Inc. since 2006 and the Chief Executive Officer at ClinTest International.
Dr. Borgonha's former jobs include being the Medical Director at Martindale Pharmaceuticals Ltd.
from 2011 to 2012, the Medical Director at Strand Genomics, Inc. from 2014 to 2018, and the Vice President-Clinical Development at Capricor Therapeutics, Inc. Dr. Borgonha completed his undergraduate degree at Massachusetts Institute of Technology in 2001 and at St. John's Medical College in 1997.
Aktive Positionen von Sudhir Borgonha
Unternehmen | Position | Beginn |
---|---|---|
Translational Medicine India, Inc.
Translational Medicine India, Inc. Miscellaneous Commercial ServicesCommercial Services Translational Medicine India, Inc. provides clinical research solutions. It offers a novel therapeutic with biomarkers and early stage clinical trials for researchers. The company is headquartered in Waltham, MA. | Chief Executive Officer | 01.01.2006 |
ClinTest International | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Sudhir Borgonha
Unternehmen | Position | Ende |
---|---|---|
ten3t Healthcare Pvt Ltd.
ten3t Healthcare Pvt Ltd. Packaged SoftwareTechnology Services Ten3t Healthcare Pvt Ltd. develops wearable medical devices. Its product Cicer collects and integrates medical grade data in real time. The company was founded by Sudhir Borgonha, Rahul Shingrani and Prasad Bhat on October 21, 2014 and is headquartered in Bangalore, India. | Founder | 01.01.2020 |
Strand Genomics, Inc.
Strand Genomics, Inc. Medical/Nursing ServicesHealth Services Part of Reliance Industries Ltd., Strand Genomics, Inc. is a private company that uses liquid biopsy to monitor colorectal cancer. The company is based in Aurora, CO. Colorectal cancer is the second most common cancer worldwide after lung cancer. The company offers single gene testing as well as a 48-gene panel and a 152-gene panel test for colorectal cancer. A liquid biopsy approach to address the surveillance of colorectal cancer in treated patients and also to study the efficacy of the treatment regimen is under development and will be available to doctors and patients in the near future. The liquid biopsy approach has become a promising new method for monitoring therapy response, disease progression and even relapse long before any other screening method would be able to detect that the cancer has relapsed. | Chief Tech/Sci/R&D Officer | 01.01.2018 |
Martindale Pharmaceuticals Ltd.
Martindale Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Martindale Pharmaceuticals Ltd. manufactures and distributes pharmaceutical products. The firm offers injectable products, pre-filled syringes, ophthalmic drops, ointments, oral solutions, and suppositories. The company was founded on September 22, 1972 and is headquartered in Romford, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01.01.2012 |
CAPRICOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Angstrom Medica, Inc.
Angstrom Medica, Inc. Medical SpecialtiesHealth Technology Part of Resolve Surgical Technologies, Inc., Angstrom Medica, Inc. manufactures biomaterials and medical devices. The private company is based in Woburn, MA. The company was founded by Sudhir Borgonha, Edward S. Ahn. Angstrom Medica was acquired by Resolve Surgical Technologies, Inc. on October 24, 2007. | Founder | - |
Ausbildung von Sudhir Borgonha
Massachusetts Institute of Technology | Undergraduate Degree |
St. John's Medical College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Angstrom Medica, Inc.
Angstrom Medica, Inc. Medical SpecialtiesHealth Technology Part of Resolve Surgical Technologies, Inc., Angstrom Medica, Inc. manufactures biomaterials and medical devices. The private company is based in Woburn, MA. The company was founded by Sudhir Borgonha, Edward S. Ahn. Angstrom Medica was acquired by Resolve Surgical Technologies, Inc. on October 24, 2007. | Health Technology |
Translational Medicine India, Inc.
Translational Medicine India, Inc. Miscellaneous Commercial ServicesCommercial Services Translational Medicine India, Inc. provides clinical research solutions. It offers a novel therapeutic with biomarkers and early stage clinical trials for researchers. The company is headquartered in Waltham, MA. | Commercial Services |
ClinTest International | |
Martindale Pharmaceuticals Ltd.
Martindale Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Martindale Pharmaceuticals Ltd. manufactures and distributes pharmaceutical products. The firm offers injectable products, pre-filled syringes, ophthalmic drops, ointments, oral solutions, and suppositories. The company was founded on September 22, 1972 and is headquartered in Romford, the United Kingdom. | Health Technology |
Strand Genomics, Inc.
Strand Genomics, Inc. Medical/Nursing ServicesHealth Services Part of Reliance Industries Ltd., Strand Genomics, Inc. is a private company that uses liquid biopsy to monitor colorectal cancer. The company is based in Aurora, CO. Colorectal cancer is the second most common cancer worldwide after lung cancer. The company offers single gene testing as well as a 48-gene panel and a 152-gene panel test for colorectal cancer. A liquid biopsy approach to address the surveillance of colorectal cancer in treated patients and also to study the efficacy of the treatment regimen is under development and will be available to doctors and patients in the near future. The liquid biopsy approach has become a promising new method for monitoring therapy response, disease progression and even relapse long before any other screening method would be able to detect that the cancer has relapsed. | Health Services |
ten3t Healthcare Pvt Ltd.
ten3t Healthcare Pvt Ltd. Packaged SoftwareTechnology Services Ten3t Healthcare Pvt Ltd. develops wearable medical devices. Its product Cicer collects and integrates medical grade data in real time. The company was founded by Sudhir Borgonha, Rahul Shingrani and Prasad Bhat on October 21, 2014 and is headquartered in Bangalore, India. | Technology Services |